THE STUDY
It is not accurate to refer to the patient numbers in the abstract. They took part in an earlier study -the current study compared their responses to the specialists' responses.
There needs to be greater reflection on the characteristics of the participants. It looks as if they were a hand picked group at conferences. This is the main flaw of this study -and the study is only credible if the authors acknowledge this. Also have they reflected on who gathers patient experience. Is it the most senior members of terms who go to international conferences or is it junior colleague and specialists nurses? That is not to argue senior doctors don't need to know about this issues. 
RESULTS & CONCLUSIONS

GENERAL COMMENTS
This is one of the first studies in colorectal surgery comparing POMs (Patient Oriented measurements) with the clinicians beliefs and understanding of patients' symptom burdens. Hopefully, this will be more focused on in future research in general. This is also a good reason for publishing in a more general journal as BMJOpen. The paper is well written, the hypothesis well formulated and the chosen methodology well suited for anwering the hypothesis. The presentation of the results sould be more accurate and clear according to what is the main finding and message in the paper. The discussion is relevant, to the point and summarise the study adequately.
VERSION 1 -AUTHOR RESPONSE
Reviewer 1
Reviewer's comment: This study raises the question of management of LARS. Who is supposed to manage these problems? In our center, one physician gastroenterologist is in charge of it. It would be interesting to ask this question to the panel, if possible.
Response: We know that at many centres, including our own, LARS is managed by colorectal surgeons. Our view is that as long as there is clear delegation of who is in charge of LARS management at the centre, and the managing clinician has a good understanding of LARS and its management options, which is also in line with the patient's experience and expectations, then the specialty of the managing clinician is probably not of high importance. We are interested in repeating the study in a few years, at which time more questions can be posed to the expert panel, including who should manage LARS.
Reviewer's comment: Some of the members of the expert panel have published papers on functional outcome after rectal cancer treatment. It would be interesting to check -again if possible -if the answers of these specialists are different.
Response: With the participants being world-leading experts, many have indeed published papers on functional outcome after rectal cancer treatment. We believe that instead of grouping the experts according to publishing status, the current grouping based on whether the expert deals with functional bowel disorders regularly would be more consistent with daily practice.
Reviewer 2
Reviewer's comment: It is not accurate to refer to the patient numbers in the abstract. They took part in an earlier study -the current study compared their responses to the specialists' responses.
Response: We have removed the sentence "961 patients who received sphincter-preserving rectal cancer treatment." from the Participants section of the Abstract (page 2, paragraph 4).
Reviewer's comment: There needs to be greater reflection on the characteristics of the participants. It looks as if they were a hand picked group at conferences. This is the main flaw of this study -and the study is only credible if the authors acknowledge this. Also have they reflected on who gathers patient experience. Is it the most senior members of terms who go to international conferences or is it junior colleague and specialists nurses? That is not to argue senior doctors don't need to know about this issues.
Response: We have already acknowledged the limitation of our participant selection, both under the Strengths and limitations of this study section of the Article summary: "However, the generalisability of the results could be limited by the fact that the sample of specialists was drawn from five European colorectal conferences." (page 5, first paragraph), and the Discussion: "On the other hand, the generalisability of the results could be limited by the sample of specialists recruited, since it is confined to five particular European colorectal conferences." (page 13, first line). We thought that it would be most interesting to evaluate the knowledge of LARS among world-leading experts, who should guide and educate their colleagues in identifying and addressing the syndrome. Although it may be junior doctors and nurse specialists who are more involved in gathering patient experience firsthand, senior members of the team must be aware of relevant issues for the patient, as they are ultimately responsible for the care provided and the sharing of knowledge.
Reviewer's comment: Is the main message not that, as yet, the results of the authors' work developing the tool have been poorly disseminated to their peers? Presumably they carried out the work developing and validating the LARS-score because the didn't know the answer to the question. So why should their colleagues? What are they doing to disseminate and implement their findings.
Response: The LARS score was first published in May 2012, and the study was conducted in MayAugust 2012. Therefore at the time of the study, we did not expect that the LARS score would be wellknown. The study provides a current snapshot of the expert's knowledge of LARS in relation to the patient, and serves to improve the understanding of LARS and raise the profile of the LARS score. Apart from publications, we have presented the LARS score and its related research at numerous conferences. In addition, we are working with other researchers, clinicians, and healthcare management professionals, to incorporate the LARS score in routine follow-up after sphincterpreserving rectal cancer treatment in Denmark, Sweden, and The Netherlands. We will continue to disseminate and implement the LARS score. As stated in the response to Reviewer 1 above, we are interested in repeating the study in a few years, and we expect to see an increase in knowledge. We have added "Work is underway to incorporate the LARS score in routine follow-up after sphincterpreserving rectal cancer treatment in Denmark, Sweden, and The Netherlands." in the Discussion (page 14, first paragraph, line 2).
Reviewer 3
Reviewer's comment: The presentation of the results should be more accurate and clear according to what is the main finding and message in the paper.
Response: We have added "Although the specialists performed better than random, there was considerable discrepancy between the specialist's perspective and patient experience." in the Discussion (page 12, paragraph 3, line 5).
Other changes:
-Page 1: positions of authors removed, and conference presentation information of the study added.
-Page 2, second to last line: … in the LARS score, "was" compared with the frequency of being selected at random.
-Page 7, line 1: … "many" of the scales of the European Organisation for Research and Treatment… -Page 7, paragraph 3, line 3: These specialists were "mostly" keynote speakers moderators, or faculty members of the conference.
-Page 9, line 3: …administered by one of the authors (TYTC) via "an internet teleconferencing" session.
-Page 10, paragraph 4, line 4: … in the "internet teleconferencing" session due to time commitments.
-Page 10, last paragraph, line 2: …frequency of being chosen at random, "is" displayed in figure 2.
-Page 11, Table 1 : expected number of specialists rounded to the closest integer.
-Page 14, paragraph 2, line 5: … have influenced the clinician "to think" that LARS is predominantly about faecal incontinence.
-Page 18: updates to reference 12 and 13.
